Project Details
Description
Gene therapy is the use of DNA as a drug to treat disease by delivering therapeutic DNA into a patient's cells. In this project we will implement cardiovascular and muscle-specific "targeting" for gene therapy of neuromuscular disorders.
| Acronym | FWOAL690 |
|---|---|
| Status | Finished |
| Effective start/end date | 1/01/13 → 31/12/16 |
Keywords
- Fibrosis
- Hepatic Stellate Cells
- Histon (de)acetylation
- Stellate cell activation
- Liver Cell Transplantation
- Liver Sinusoidal Cells
- Portal hypertension
- Sinusoidal Cells
- cirrhosis
- Cytoskeleton
- Cell Biology
- Fat-Storing Cells
- NASH / NAFLD
- Intermediate Filaments
- liver stem / progenitor cells
- autophagy
- Flow Cytometry
- Metabolic Syndrome
Flemish discipline codes in use since 2023
- Morphological sciences
- Oncology
- Gene and molecular therapy
- Multimedia processing
- Molecular medicine
- Immunology
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.